Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes who have diabetic peripheral neuropathy are more likely to experience severe ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of a hybrid closed-loop insulin delivery system ...

Sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes, research indicates. Sotagliflozin has shown promise in improving glucose control without any ...

LISBON, PORTUGAL — Dapagliflozin (Farxiga/Forxiga, AstraZeneca) improves glycemic control and induces weight loss in patients with inadequately controlled type 1 diabetes, shows the first phase 3 ...

(HealthDay News) — For young patients with type 1 diabetes, insulin pump therapy is associated with lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than ...

Children who had a single episode of moderate/severe diabetic ketoacidosis (DKA) and were newly diagnosed with type 1 diabetes had a subtle decline in a long-term memory task when they were tested a ...

Clinical trial data has shown that the drug helped 28.6% of patients achieve glycated hemoglobin of 7.0% of less by week 24 without severe hypoglycemia or diabetic ketoacidosis and also helped ...

ORLANDO – Treatment with two different doses of sotagliflozin paired with insulin therapy was associated with statistically significant A1C reductions in patients with type 1 diabetes. researchers ...